查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1450296

脉衝场消融（PFA）系统市场：现况分析与预测（2023-2030）

Pulsed Field Ablation (PFA) System Market: Current Analysis and Forecast (2023-2030)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 158 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

由于更容易罹患心臟病的老年人口的增加，脉衝场消融（PFA）系统市场预计将稳定成长约25.1%。 例如，2022年10月，世界卫生组织（WHO）宣布，到2050年，全球60岁以上人口将翻一番，达到21亿。 2020 年至 2050 年间，80 岁及以上的人口数量预计将增加两倍，达到 4.26 亿。 在预测期内，有几个因素正在推动市场成长，例如心臟病和呼吸系统疾病盛行率的急剧上升、对心血管疾病的认识不断提高以及对心臟病学的投资增加。 除此之外，透过脉衝场消融（PFA）系统提高治疗效率可以加快治疗过程并提高准确性，这也稳步推动了脉衝场消融（PFA）系统市场的发展。

市场依治疗领域分为心血管疾病、肿瘤疾病、呼吸系统疾病等。 由于越来越多的老年人更容易患心房颤动等心臟病，心血管疾病领域将在 2022 年在全球脉衝场消融 (PFA) 系统市场中占据最大份额。 例如，根据美国国立卫生研究院2023年8月的数据，心房颤动的盛行率随着年龄的增长而增加，65岁以上的人中有5%、80岁以上的人有10%患有此病。据说确实有。 由于对微创手术的需求不断增加，该市场已显着成长。 心臟病家族史也是该细分市场的驱动因素。 因此，在治疗领域中，心血管疾病领域将在2022年占据很大的市场。

依产品组成，市场分为导管和产生器。 由于发电机提供的能源供应精度较高，预计发电机产业在预测期内将占据较大份额。 例如，2024 年 1 月，波士顿科学公司的 FARAPULSE 现场消融 (PFA) 系统获得美国食品药物管理局 (FDA) 批准。 FARAPULSE 现场消融 (PFA) 系统配备了名为 FARASTAR PFA 产生器的先进发生器。 发生器是 PFA 系统的重要组成部分，因为它产生组织消融所需的脉衝电场。 发电机技术的进步，例如增强的控制机制和改进的安全功能，有助于在各种医疗程序中更多地采用 PFA 系统。 此外，PFA技术的应用正在从心血管疾病扩展到癌症和神经系统疾病等其他疾病，从而推动了对更先进和多功能发电机的需求。 因此，在产品组件中，发电机类别预计在预测期内呈现高复合年增长率。

根据应用，市场分为消融和消融测绘。 2022年，消融细分市场在细分市场中占据最大份额。 PFA 的优点，例如提高精确度、减少对周围组织的附带损伤以及缩短手术时间，正在推动 PFA 系统消融市场的扩张。 因此，在2022年的市场中，消融领域将在应用领域中占有较大份额。

为了更了解脉衝场消融 (PFA) 系统的市场实施情况，我们根据其在北美、欧洲、亚太地区和世界其他地区的全球影响力对市场进行了分析。 预计在预测期内，亚太地区全球脉衝场消融 (PFA) 系统市场将以高复合年增长率成长。 许多亚太国家的人口老化，加上生活方式因素，正在增加心律不整和其他可以使用 PFA 系统治疗的疾病的盛行率。 其他几个因素，例如各种脉衝场消融（PFA）系统的市场发展激增、可及性的提高以及医疗保健成本的多样化，正在推动预测期内的市场成长。 该地区正在实施一项关于心血管疾病的重大宣传计划。 例如，SEAHEARTS（WHO HEARTS一揽子计画在东南亚地区的改编版）与2023年世界心臟日的主题 "使用心臟，了解心臟" 产生共鸣，并为各国提供了改善心臟病现状的路线图。 因此，预计亚太地区在预测期内将表现出更高的复合年增长率。

市场上营运的主要公司包括 Boston Scientific Corporation、Kardium、Abbott、Galvanize Therapeutics, Inc.、MIRAI MEDICAL、Pulse Biosciences, Inc.、AccuPulse Medical、Acutus Medical, Inc. 和 CathRx Ltd.、AccuPulse Medical、和更多。

目录

第1章市场介绍

  • 市场定义
  • 主要目标
  • 利害关係人
  • 限制

第2章研究方法或前提

  • 调查过程
  • 调查方法
  • 受访者简介

第3章市场总结

第 4 章执行摘要

第 5 章 COVID-19 对脉衝场消融 (PFA) 系统市场的影响

第 6 章脉衝场消融 (PFA) 系统市场收入（2020-2030 年）

第 7 章市场洞察：依治疗领域

  • 心血管疾病
  • 肿瘤疾病
  • 呼吸系统疾病
  • 其他

第 8 章市场洞察：按产品组件

  • 导管
  • 发电机

第 9 章市场洞察：按应用划分

  • 消融
  • 消融和映射

第 10 章市场洞察：按地区

  • 北美
    • 美国
    • 加拿大
    • 北美其他地区
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 亚太地区其他地区
  • 世界其他地区

第 11 章脉衝场消融 (PFA) 系统市场动态

  • 市场驱动因素
  • 市场挑战
  • 影响分析

第 12 章脉衝场消融 (PFA) 系统市场机会

第 13 章脉衝场消融 (PFA) 系统市场趋势

第14章需求面与供给面分析

  • 需求方分析
  • 供给面分析

第 15 章价值链分析

第16章竞争场景

  • 竞争状况
    • 波特五力分析

第17章公司简介

  • Boston Scientific Corporation
  • Kardium
  • Abbott
  • Galvanize Therapeutics, Inc.
  • MIRAI MEDICAL
  • Pulse Biosciences, Inc.
  • AccuPulse Medical
  • Acutus Medical, Inc.
  • CathRx Ltd.
  • AccuPulse Medical

第18章 免责事项

简介目录
Product Code: UMHE212630

Pulsed field ablation (PFA) system is an innovative medical technology used for the treatment of various cardiac arrhythmias and other medical conditions. Unlike traditional ablation techniques that use thermal energy to create lesions on target tissues, PFA relies on the delivery of pulsed electric fields to achieve tissue ablation. The introduction of PFA systems represents a significant advancement in the field of electrophysiology and minimally invasive procedures. The pulsed field ablation (PFA) system has been gaining traction in the market due to several factors, such as increasing incidence of atrial fibrillation, advancements in technology, growing minimally invasive procedures, increasing awareness and diagnosis, rising healthcare expenditure, rising regulatory support, and surge in company collaborations & partnerships are leading drivers of pulsed field ablation (PFA) systems globally.

The Pulsed Field Ablation (PFA) Systems Market is expected to grow at a steady rate of around 25.1% owing to the rising geriatric population which is more prone to heart disorders. For instance, in October 2022, according to the World Health Organization, by 2050, the world's population of people aged 60 years and older will double to 2.1 billion. The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. Several factors, including a surge in the incidence of cardiac and respiratory disorders, increasing awareness regarding cardiovascular disorders, and increased investments in cardiology departments are driving the growth of the market during the forecast period. Apart from this, accelerated treatment efficiency with pulsed field ablation (PFA) systems has resulted in faster treatment procedures and better accuracy which is also driving this market of pulsed field ablation (PFA) systems at a steady rate.

Based on therapeutic areas, the market is segmented into cardiovascular disorders, oncological disorders, respiratory disorders, and others. The cardiovascular disorders segment held the maximum share in the global market of pulsed field ablation (PFA) systems in 2022 owing to the rising geriatric population which is more prone to heart disorders like atrial fibrillation. For instance, in August 2023, according to the National Institutes of Health, the prevalence of atrial fibrillation increases with age, with 5% of individuals over the age of 65 and 10% of those over the age of 80 having this condition. The market experienced significant growth due to the increasing demand for minimally invasive procedures. A family history of heart disease is also a propelling factor for this segment. Thus, among the therapeutic areas, the cardiovascular disorders segment held a significant share of the market in 2022.

Based on product components, the market is bifurcated into catheters and generators. The generators segment is expected to hold a significant share of the market in the forecast period owing to the better energy delivery precision by generators. For instance, in January 2024, Boston Scientific Corporation received U.S. Food and Drug Administration (FDA) approval for the FARAPULSE Field Ablation (PFA) System which has an advanced generator named FARASTAR PFA Generator which is designed for an easy three-button click to prepare, confirm and deliver therapy using bipolar & biphasic waveforms with proprietary pulses. Generators are essential components of PFA systems as they produce the pulsed electric fields required for tissue ablation. The advancements in generator technology, such as enhanced control mechanisms, and improved safety features, have contributed to the growing adoption of PFA systems for various medical procedures. Additionally, the expanding applications of PFA technology beyond cardiovascular diseases to other conditions such as cancer and neurological disorders have driven the demand for more advanced and versatile generators. Thus, amongst product components, the generators category is expected to witness a higher CAGR during the forecast period.

Based on the application area, the market is bifurcated into ablation and ablation & mapping. The ablation segment held the maximum share in the global market of pulsed field ablation (PFA) systems in 2022 owing to the desired controlled ablation provided by the device. The advantages of PFA such as improved precision, reduced collateral damage to surrounding tissues, and potentially shorter procedure times, have fueled the expansion of the ablation segment within the PFA system market. Thus, among the application areas, the ablation segment held a significant share of the market in 2022.

For a better understanding of the market adoption of pulsed field ablation (PFA) systems, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. APAC is expected to grow with a high CAGR in the global pulsed field ablation (PFA) system market in the forecast period. The aging population in many APAC countries, combined with lifestyle factors, has resulted in a higher prevalence of cardiac arrhythmias and other conditions that can be treated using PFA systems. Several other factors such as a surge in the development of a wide range of pulsed field ablation (PFA) systems, enhanced accessibility, and diversified healthcare costs are driving the market's growth during the forecast period. There have been major awareness programs regarding cardiovascular disorders in the region. For instance, SEAHEARTS (WHO HEARTS package adaptation to South-East Asia Region) resonated with the World Heart Day 2023 theme 'Use Heart, Know Heart' and offered countries a roadmap to scale up their current situations of heart disorders. Thus, APAC is expected to witness a higher CAGR during the forecast period.

Some of the major players operating in the market include Boston Scientific Corporation; Kardium; Abbott; Galvanize Therapeutics, Inc.; MIRAI MEDICAL; Pulse Biosciences, Inc.; AccuPulse Medical; Acutus Medical, Inc.; CathRx Ltd.; AccuPulse Medical.

TABLE OF CONTENTS

1. MARKET INTRODUCTION

  • 1.1.Market Definitions
  • 1.2.Main Objective
  • 1.3.Stakeholders
  • 1.4.Limitation

2. RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1.Research Process of the Pulsed Field Ablation (PFA) System Market
  • 2.2.Research Methodology of the Pulsed Field Ablation (PFA) System Market
  • 2.3.Respondent Profile

3. MARKET SYNOPSIS

4. EXECUTIVE SUMMARY

5. IMPACT OF COVID-19 ON THE PULSED FIELD ABLATION (PFA) SYSTEM MARKET

6. PULSED FIELD ABLATION (PFA) SYSTEM MARKET REVENUE (USD BN), 2020-2030F

7. MARKET INSIGHTS BY THERAPEUTIC AREA

  • 7.1.Cardiovascular Disorders
  • 7.2.Oncological Disorders
  • 7.3.Respiratory Disorders
  • 7.4.Others

8. MARKET INSIGHTS BY PRODUCT COMPONENTS

  • 8.1.Catheter
  • 8.2.Generator

9. MARKET INSIGHTS BY APPLICATION AREA

  • 9.1.Ablation
  • 9.2.Ablation & Mapping

10. MARKET INSIGHTS BY REGION

  • 10.1.North America
    • 10.1.1.U.S.
    • 10.1.2.Canada
    • 10.1.3.Rest of North America
  • 10.2.Europe
    • 10.2.1.Germany
    • 10.2.2.U.K.
    • 10.2.3.France
    • 10.2.4.Italy
    • 10.2.5.Spain
    • 10.2.6.Rest of Europe
  • 10.3.Asia-Pacific
    • 10.3.1.China
    • 10.3.2.Japan
    • 10.3.3.India
    • 10.3.4.Rest of Asia-Pacific
  • 10.4.Rest of World

11. PULSED FIELD ABLATION (PFA) SYSTEM MARKET DYNAMICS

  • 11.1.Market Drivers
  • 11.2.Market Challenges
  • 11.3.Impact Analysis

12. PULSED FIELD ABLATION (PFA) SYSTEM MARKET OPPORTUNITIES

13. PULSED FIELD ABLATION (PFA) SYSTEM MARKET TRENDS

14. DEMAND AND SUPPLY-SIDE ANALYSIS

  • 14.1.Demand Side Analysis
  • 14.2.Supply Side Analysis

15. VALUE CHAIN ANALYSIS

16. COMPETITIVE SCENARIO

  • 16.1.Competitive Landscape
    • 16.1.1.Porters Fiver Forces Analysis

17. COMPANY PROFILED

  • 17.1.Boston Scientific Corporation
  • 17.2.Kardium
  • 17.3.Abbott
  • 17.4.Galvanize Therapeutics, Inc.
  • 17.5.MIRAI MEDICAL
  • 17.6.Pulse Biosciences, Inc.
  • 17.7.AccuPulse Medical
  • 17.8.Acutus Medical, Inc.
  • 17.9.CathRx Ltd.
  • 17.10.AccuPulse Medical

18. DISCLAIMER